• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻腔及鼻窦成人T细胞白血病/淋巴瘤:四例报告

Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report.

作者信息

Nagano Hiromi, Matsumoto Hayato, Miyamoto Yumi, Takumi Koji, Nakajo Masatoyo, Yamashita Masaru

机构信息

Department of Otolaryngology Head and Neck Surgery, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.

Department of Radiology, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima, 890-8520 Japan.

出版信息

Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):1264-1271. doi: 10.1007/s12070-023-04258-3. Epub 2023 Oct 13.

DOI:10.1007/s12070-023-04258-3
PMID:38440568
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10908978/
Abstract

Adult T-cell leukemia/lymphoma (ATL) is a form of leukemia caused by the human T-cell leukemia virus type I (HTLV-1). Otolaryngologists often diagnose ATL based on cervical lymphadenopathy or Waldeyer ring lesions. However, there are few reports of ATL occurring in the nasal and paranasal cavity. Here, we report four such cases of ATL. Case 1: An 82-year-old man diagnosed with acute-type ATL with a tumor in the nasal cavity underwent 5 courses of THP-COP, but died after 36 months due to ATL. Case 2: A 62-year-old woman diagnosed with lymphoma-type ATL with a tumor in the frontal sinus was treated with 5 courses of VCAP-AMP-VECP, and has survived for more than 10 years. Case 3: A 64-year-old man diagnosed with lymphoma-type ATL with a tumor in the maxillary sinus underwent 8 courses of VCAP-AMP-VECP and 2 courses of mogamulizumab, but died after 34 months due to ATL. Case 4: A 52-year-old woman diagnosed with lymphoma-type ATL with tumors in both ethmoid sinuses received 2 courses of CHOP, 2 courses of DeVIC, radiotherapy (32 Gy) and 2 courses of mogamulizumab, but died after 9 months due to ATL.

摘要

成人T细胞白血病/淋巴瘤(ATL)是一种由I型人类T细胞白血病病毒(HTLV-1)引起的白血病。耳鼻喉科医生常根据颈部淋巴结肿大或瓦尔代尔环病变来诊断ATL。然而,鼻腔和鼻窦发生ATL的报道较少。在此,我们报告4例此类ATL病例。病例1:一名82岁男性被诊断为急性型ATL,鼻腔有肿瘤,接受了5个疗程的THP-COP治疗,但36个月后因ATL死亡。病例2:一名62岁女性被诊断为淋巴瘤型ATL,额窦有肿瘤,接受了5个疗程的VCAP-AMP-VECP治疗,已存活超过10年。病例3:一名64岁男性被诊断为淋巴瘤型ATL,上颌窦有肿瘤,接受了8个疗程的VCAP-AMP-VECP和2个疗程的莫加莫拉单抗治疗,但34个月后因ATL死亡。病例4:一名52岁女性被诊断为淋巴瘤型ATL,筛窦有肿瘤,接受了2个疗程的CHOP、2个疗程的DeVIC、放疗(32 Gy)和2个疗程的莫加莫拉单抗治疗,但9个月后因ATL死亡。

相似文献

1
Adult T-cell Leukemia/Lymphoma (ATL) in the Nasal and Paranasal Cavity: Four Cases Report.鼻腔及鼻窦成人T细胞白血病/淋巴瘤:四例报告
Indian J Otolaryngol Head Neck Surg. 2024 Feb;76(1):1264-1271. doi: 10.1007/s12070-023-04258-3. Epub 2023 Oct 13.
2
Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).人源化CCR4抗体(莫格利珠单抗)对一家机构在三年期间(2012 - 2014年)治疗的14例侵袭性成人T细胞白血病 - 淋巴瘤患者的临床影响
Intern Med. 2016;55(11):1439-45. doi: 10.2169/internalmedicine.55.6312. Epub 2016 Jun 1.
3
[Intracranial and orbital extension of a nasal cavity adult T-cell leukemia: a case report].
No Shinkei Geka. 1999 Jan;27(1):55-9.
4
Possibility of a risk-adapted treatment strategy for untreated aggressive adult T-cell leukaemia-lymphoma (ATL) based on the ATL prognostic index: a supplementary analysis of the JCOG9801.基于 ATL 预后指数的未治疗侵袭性成人 T 细胞白血病/淋巴瘤(ATL)风险适应治疗策略的可能性:JCOG9801 的补充分析。
Br J Haematol. 2019 Aug;186(3):440-447. doi: 10.1111/bjh.15950. Epub 2019 May 16.
5
Treatment of aggressive adult T-cell leukemia/lymphoma: a retrospective study in a hospital located in HTLV-1 highly endemic area.侵袭性成人 T 细胞白血病/淋巴瘤的治疗:在 HTLV-1 高度流行地区的一家医院进行的回顾性研究。
Int J Hematol. 2020 Feb;111(2):234-240. doi: 10.1007/s12185-019-02769-w. Epub 2019 Nov 12.
6
VCAP-AMP-VECP as a preferable induction chemotherapy in transplant-eligible patients with aggressive adult T-cell leukemia-lymphoma: a propensity score analysis.VCAP-AMP-VECP 作为适合移植的侵袭性成人 T 细胞白血病/淋巴瘤患者的诱导化疗:倾向评分分析。
Bone Marrow Transplant. 2019 Sep;54(9):1399-1405. doi: 10.1038/s41409-019-0446-z. Epub 2019 Jan 21.
7
Successful treatment with lenalidomide for relapsed adult T-cell leukemia/lymphoma after cord blood cell transplantation.来那度胺成功治疗脐血细胞移植后复发的成人T细胞白血病/淋巴瘤。
Blood Cell Ther. 2021 Apr 30;4(2):44-47. doi: 10.31547/bct-2020-018. eCollection 2021 May 25.
8
Adult T-Cell Leukemia-Lymphoma.成人T细胞白血病-淋巴瘤
Cancer Treat Res. 2019;176:145-161. doi: 10.1007/978-3-319-99716-2_7.
9
Clinical Features and Treatment Outcomes of 81 Patients with Aggressive Type Adult T-cell Leukemia-lymphoma at a Single Institution over a 7-year Period (2006-2012).单机构7年期间(2006 - 2012年)81例侵袭性成人T细胞白血病-淋巴瘤患者的临床特征及治疗结果
Intern Med. 2015;54(12):1489-98. doi: 10.2169/internalmedicine.54.1953. Epub 2015 Jun 15.
10
Prognosis of patients with adult T-cell leukemia/lymphoma in Japan: A nationwide hospital-based study.日本成人 T 细胞白血病/淋巴瘤患者的预后:一项基于全国医院的研究。
Cancer Sci. 2020 Dec;111(12):4567-4580. doi: 10.1111/cas.14658. Epub 2020 Oct 21.

本文引用的文献

1
CCR4 as a Therapeutic Target for Cancer Immunotherapy.CCR4作为癌症免疫治疗的一个治疗靶点。
Cancers (Basel). 2021 Nov 4;13(21):5542. doi: 10.3390/cancers13215542.
2
Human T-cell leukaemia virus type I and adult T-cell leukaemia-lymphoma.人类 T 细胞白血病病毒 I 型与成人 T 细胞白血病/淋巴瘤。
Lancet Oncol. 2014 Oct;15(11):e517-26. doi: 10.1016/S1470-2045(14)70202-5.
3
Mogamulizumab: first global approval.莫格利珠单抗:全球首次批准。
Drugs. 2012 Jun 18;72(9):1293-8. doi: 10.2165/11631090-000000000-00000.
4
Current prevalence of HTLV-1 in Japan as determined by screening of blood donors.日本通过献血筛查确定的 HTLV-1 目前流行率。
J Med Virol. 2012 Feb;84(2):327-35. doi: 10.1002/jmv.23181.
5
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult T-cell leukemia/lymphoma: a multicenter phase II study.THP-COP 方案治疗外周 T 细胞淋巴瘤和成人 T 细胞白血病/淋巴瘤:一项多中心 II 期研究。
Eur J Haematol. 2010 May;84(5):391-7. doi: 10.1111/j.1600-0609.2010.01411.x. Epub 2010 Jan 5.
6
Adult T-cell leukaemia/lymphoma.成人T细胞白血病/淋巴瘤
J Clin Pathol. 2007 Dec;60(12):1373-7. doi: 10.1136/jcp.2007.052456.
7
Adult T-cell leukemia/lymphoma with multiple integration of HTLV-1 provirus presenting as an isolated paranasal sinus tumor: a case report.成人T细胞白血病/淋巴瘤伴人T细胞白血病病毒1型前病毒多处整合,表现为孤立性鼻窦肿瘤:一例报告
Head Neck. 2008 Jun;30(6):815-20. doi: 10.1002/hed.20730.
8
VCAP-AMP-VECP compared with biweekly CHOP for adult T-cell leukemia-lymphoma: Japan Clinical Oncology Group Study JCOG9801.成人T细胞白血病-淋巴瘤中,VCAP-AMP-VECP方案与每两周一次的CHOP方案的比较:日本临床肿瘤学组研究JCOG9801
J Clin Oncol. 2007 Dec 1;25(34):5458-64. doi: 10.1200/JCO.2007.11.9958. Epub 2007 Oct 29.
9
Sinonasal lymphoma: a clinicopathologic analysis of 58 cases from the Massachusetts General Hospital.鼻窦淋巴瘤:来自麻省总医院的58例临床病理分析
Am J Surg Pathol. 1999 Nov;23(11):1356-69. doi: 10.1097/00000478-199911000-00006.
10
Adult T-cell leukemia with initial presentation as sinonasal lymphoma: report of two cases.
J Oral Maxillofac Surg. 1993 May;51(5):584-7. doi: 10.1016/s0278-2391(10)80520-8.